Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription

被引:61
作者
Zhou, MS
Deng, LW
Lacoste, V
Park, HU
Pumfery, A
Kashanchi, F
Brady, JN
Kumar, A
机构
[1] NCI, Cellular Oncol Lab, Virus Tumor Biol Sect, NIH, Bethesda, MD 20892 USA
[2] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA
[3] Inst Genom Res, Rockville, MD USA
关键词
D O I
10.1128/JVI.78.24.13522-13533.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) Tat protein recruits positive transcription elongation factor b (P-TEFb) to the transactivation response (TAR) RNA structure to facilitate formation of processive transcription elongation complexes (TECs). Here we examine the role of the Tat/TAR-specified cyclin-dependent kinase 9 (CDK9) kinase activity in regulation of HIV-1 transcription elongation and histone methylation. In HIV-1 TECs, P-TEFb phosphorylates the RNA polymerase II (RNAP II) carboxyl-terminal domain (CTD) and the transcription elongation factors SPT5 and Tat-SF1 in a Tat/TAR-dependent manner. Using in vivo chromatin immunoprecipitation analysis, we demonstrate the following distinct properties of the HIV-1 transcription complexes. First, the RNAP II CTD is phosphorylated at Ser 2 and Ser 5 near the promoter and at downstream coding regions. Second, the stable association of SPT5 with the TECs is dependent upon P-TEFb kinase activity. Third, P-TEFb kinase activity is critical for the induction of methylation of histone H3 at lysine 4 and lysine 36 on HIV-1 genes. Flavopiridol, a potent P-TEFb kinase inhibitor, inhibits CTD phosphorylation, stable SPT5 binding, and histone methylation, suggesting that its potent antiviral activity is due to its ability to inhibit several critical and unique steps in HIV-1 transcription elongation.
引用
收藏
页码:13522 / 13533
页数:12
相关论文
共 78 条
[1]   High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo:: roles in promoter proximal pausing and transcription elongation [J].
Andrulis, ED ;
Guzmán, E ;
Döring, P ;
Werner, J ;
Lis, JT .
GENES & DEVELOPMENT, 2000, 14 (20) :2635-2649
[2]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[3]   Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat [J].
Bieniasz, PD ;
Grdina, TA ;
Bogerd, HP ;
Cullen, BR .
EMBO JOURNAL, 1998, 17 (23) :7056-7065
[4]  
Boris-Lawrie Kathleen A., 1992, Gene Expression, V2, P215
[5]   Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences [J].
Bourgeois, CF ;
Kim, YK ;
Churcher, MJ ;
West, MJ ;
Karn, J .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (04) :1079-1093
[6]   The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein [J].
Bresnahan, WA ;
Albrecht, T ;
Thompson, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (34) :22075-22082
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY [J].
BUTERA, ST ;
ROBERTS, BD ;
LAM, L ;
HODGE, T ;
FOLKS, TM .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2726-2730
[8]   Flavopiridol inhibits P-TEFb and blocks HIV-1 replication [J].
Chao, SH ;
Fujinaga, K ;
Marion, JE ;
Taube, R ;
Sausville, EA ;
Senderowicz, AM ;
Peterlin, BM ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28345-28348
[9]   Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].
Chao, SH ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799
[10]  
Chen D, 1999, MOL CELL BIOL, V19, P2863